Roohollah Mirzaee Khalilabadi

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Kerman University of Medical Sciences(Current)

Gerash University of Medical Sciences

Roohollah Mirzaee Khalilabadi is an author at Kerman University of Medical Sciences specializing in chemotherapy, acute lymphoblastic leukemia treatment, and oncology.

ORCID

Publications per year

2018–2024

Publications

The telomerase inhibitor MST-312 synergistically enhances the apoptotic effect of doxorubicin in pre-B acute lymphoblastic leukemia cells

Narges Ghasemimehr, Roohollah Mirzaee Khalilabadi, Zinat Yazdani et al. · Biomedicine & Pharmacotherapy · 2018 · 29 citations

Medicine, Oncology, Pharmacology +15

Combinatorial targeting of telomerase and DNA-PK induces synergistic apoptotic effects against Pre-B acute lymphoblastic leukemia cells

Maryam Katoueezadeh, Parisa Maleki, Seyedeh Atekeh Torabizadeh et al. · Molecular Biology Reports · 2024 · 13 citations

Life Sciences, Molecular Biology, Oncology +16

Promising anti-leukemic effect of Zataria multiflora extract in combination with doxorubicin to combat acute lymphoblastic leukemia cells (Nalm-6) (in vitro and in silico)

Mahla Lashkari, Ahmad Fatemi, Hajar Mardani Valandani et al. · Scientific Reports · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

1–3 of 3